SRHE:XETRA:XETRA-Amundi Index Solutions - Amundi Index MSCI EMU SRI PAB Ucits ETF DR Cap (EUR)

ETF | Others |

Last Closing

USD 85.61

Change

+0.74 (+0.87)%

Market Cap

USD 0.19B

Volume

3.03K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.23 (-0.43%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.36%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.18 (-0.64%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.37%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.01 (-0.02%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.88 (+0.62%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

-0.21 (-0.45%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.13 (-0.26%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.32 (+0.33%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.04 (+0.37%)

USD 80.38B

ETFs Containing SRHE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.17% 62% D 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.17% 61% D- 62% D
Trailing 12 Months  
Capital Gain 12.93% 59% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.93% 57% F 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.51% 60% D- 58% F
Dividend Return 6.51% 59% D- 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.51% 73% C 79% B-
Risk Adjusted Return 100.04% 98% N/A 97% N/A
Market Capitalization 0.19B 47% F 42% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.